Integrative Medicine Medscape More red flags on peptides even as softening of FDA oversight could happen soon under RFK Jr. The Niche The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York